|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Punt CJ, Koopman M and Vermeulen L: From
tumour heterogeneity to advances in precision treatment of
colorectal cancer. Nat Rev Clin Oncol. 14:235–246. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Du C, Huang D, Peng Y, Yao Y, Zhao Y, Yang
Y, Wang H, Cao L, Zhu WG and Gu J: 5-Fluorouracil targets histone
acetyltransferases p300/CBP in the treatment of colorectal cancer.
Cancer Lett. 400:183–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ho-Tin-Noé B, Goerge T, Cifuni SM,
Duerschmied D and Wagner DD: Platelet granule secretion
continuously prevents intratumor hemorrhage. Cancer Res.
68:6851–6858. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Colkesen Y and Muderrisoglu H: The role of
mean platelet volume in predicting thrombotic events. Clin Chem Lab
Med. 50:631–634. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lian L, Xia YY, Zhou C, Shen XM, Li XL,
Han SG, Zheng Y, Gong FR, Tao M and Li W: Mean platelet volume
predicts chemotherapy response and prognosis in patients with
unresectable gastric cancer. Oncol Lett. 10:3419–3424. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vázquez-Santiago M, Vilalta N, Ziyatdinov
A, Cuevas B, Macho R, Pujol-Moix N, Carrasco M, Mateo J,
Fontcuberta J, Soria JM and Souto JC: Platelet count and
plateletcrit are associated with an increased risk of venous
thrombosis in females. Results from the RETROVE study. Thromb Res.
157:162–164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ifran A, Hasimi A, Kaptan K, Nevruz O,
Beyan C and Erbil K: Evaluation of platelet parameters in healthy
apheresis donors using the ADVIA 120. Transfus Apher Sci. 33:87–90.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oncel M, Kiyici A, Sunam GS, Sahin E and
Adam B: Evaluation of platelet indices in lung cancer patients.
Asian Pac J Cancer Prev. 16:7599–7602. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim KH, Yang SS, Yoon YS, Lim SB, Yu CS
and Kim JC: Validation of the seventh edition of the American Joint
Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in
patients with stage II and stage III colorectal carcinoma: Analysis
of 2,511 cases from a medical centre in Korea. Colorectal Dis.
13:e220–e226. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dimitrov S, Benedict C, Heutling D,
Westermann J, Born J and Lange T: Cortisol and epinephrine control
opposing circadian rhythms in T cell subsets. Blood. 113:5134–5143.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Keil S, Barabasch A, Dirrichs T, Bruners
P, Hansen NL, Bieling HB, Brümmendorf TH and Kuhl CK: Target lesion
selection: An important factor causing variability of response
classification in the response evaluation criteria for solid tumors
1.1. Invest Radiol. 49:509–517. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Buergy D, Wenz F, Groden C and Brockmann
MA: Tumor-platelet interaction in solid tumors. Int J Cancer.
130:2747–2760. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gay LJ and Felding-Habermann B:
Contribution of platelets to tumour metastasis. Nat Rev Cancer.
11:123–134. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang X, Lv Z, Yu H and Zhu J: The
clinicopathological and prognostic role of thrombocytosis in
patients with cancer: A meta-analysis. Oncol Lett. 13:5002–5008.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo T, Krzystanek M, Szallasi Z and
Szallasi A: Thrombocytosis portends adverse prognostic significance
in patients with stage II colorectal carcinoma. F1000Res.
3:1802014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen M and Geng JG: P-selectin mediates
adhesion of leukocytes, platelets, and cancer cells in
inflammation, thrombosis, and cancer growth and metastasis. Arch
Immunol Ther Exp (Warsz). 54:75–84. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ho-Tin-Noé B, Demers M and Wagner DD: How
platelets safeguard vascular integrity. J Thromb Haemost. 9 (Suppl
1):S56–S65. 2011. View Article : Google Scholar
|
|
20
|
Nakashima J, Tachibana M, Horiguchi Y, Oya
M, Ohigashi T, Asakura H and Murai M: Serum interleukin 6 as a
prognostic factor in patients with prostate cancer. Clin Cancer
Res. 6:2702–2706. 2000.PubMed/NCBI
|
|
21
|
Paule B, Belot J, Rudant C, Coulombel C
and Abbou CC: The importance of IL-6 protein expression in primary
human renal cell carcinoma: An immunohistochemical study. J Clin
Pathol. 53:388–390. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen XM, Xia YY, Lian L, Zhou C, Li XL,
Han SG, Zheng Y, Gong FR, Tao M, Mao ZQ and Li W: Mean platelet
volume provides beneficial diagnostic and prognostic information
for patients with resectable gastric cancer. Oncol Lett.
12:2501–2506. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wodarczyk M, Kasprzyk J,
Sobolewska-Wodarczyk A, Wƚodarczyk J, Tchórzewski M, Dziki A and
Dziki Ƚ: Mean platelet volume as a possible biomarker of tumor
progression in rectal cancer. Cancer Biomark. 17:411–417. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kurtoglu E, Kokcu A, Celik H, Sari S and
Tosun M: Platelet indices may be useful in discrimination of benign
and malign endometrial lesions, and early and advanced stage
endometrial cancer. Asian Pac J Cancer Prev. 16:5397–5400. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma X, Wang Y, Sheng H, Tian W, Qi Z, Teng
F and Xue F: Prognostic significance of thrombocytosis, platelet
parameters and aggregation rates in epithelial ovarian cancer. J
Obstet Gynaecol Res. 40:178–183. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karateke A, Kaplanoglu M and Baloglu A:
Relations of platelet indices with endometrial hyperplasia and
endometrial cancer. Asian Pac J Cancer Prev. 16:4905–4908. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Borsig L: The role of platelet activation
in tumor metastasis. Expert Rev Anticancer Ther. 8:1247–1255. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ay C, Pabinger I and Cohen AT:
Cancer-associated venous thromboembolism: Burden, mechanisms, and
management. Thromb Haemost. 117:219–230. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kurt M, Onal IK, Sayilir AY, Beyazit Y,
Oztas E, Kekilli M, Turhan N, Karaman K and Akdogan M: The role of
mean platelet volume in the diagnosis of hepatocellular carcinoma
in patients with chronic liver disease. Hepatogastroenterology.
59:1580–1582. 2012.PubMed/NCBI
|
|
30
|
Karaman K, Bostanci EB, Aksoy E, Kurt M,
Celep B, Ulas M, Dalgic T, Surmelioglu A, Hayran M and Akoglu M:
The predictive value of mean platelet volume in differential
diagnosis of non-functional pancreatic neuroendocrine tumors from
pancreatic adenocarcinomas. Eur J Intern Med. 22:e95–e98. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cho SY, Yang JJ, You E, Kim BH, Shim J,
Lee HJ, Lee WI, Suh JT and Park TS: Mean platelet volume/platelet
count ratio in hepatocellular carcinoma. Platelets. 24:375–377.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Inagaki N, Kibata K, Tamaki T, Shimizu T
and Nomura S: Prognostic impact of the mean platelet
volume/platelet count ratio in terms of survival in advanced
non-small cell lung cancer. Lung Cancer. 83:97–101. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kumagai S, Tokuno J, Ueda Y, Marumo S,
Shoji T, Nishimura T, Fukui M and Huang CL: Prognostic significance
of preoperative mean platelet volume in resected non-small-cell
lung cancer. Mol Clin Oncol. 3:197–201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tuncel T, Ozgun A, Emirzeoglu L, Celik S,
Bilgi O and Karagoz B: Mean platelet volume as a prognostic marker
in metastatic colorectal cancer patients treated with
bevacizumab-combined chemotherapy. Asian Pac J Cancer Prev.
15:6421–6423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li N, Yu Z, Zhang X, Liu T, Sun YX, Wang
RT and Yu KJ: Elevated mean platelet volume predicts poor prognosis
in colorectal cancer. Sci Rep. 7:102612017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mutlu H, Berk V, Karaca H, Erden A, Aslan
T and Akca Z: Treatment regimen with bevacizumab decreases mean
platelet volume in patients with metastatic colon cancer. Clin Appl
Thromb Hemost. 18:546–548. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mutlu H, Artis TA, Erden A and Akca Z:
Alteration in mean platelet volume and platicrit values in patients
with cancer that developed thrombosis. Clin Appl Thromb Hemost.
19:331–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vagdatli E, Gounari E, Lazaridou E,
Katsibourlia E, Tsikopoulou F and Labrianou I: Platelet
distribution width: A simple, practical and specific marker of
activation of coagulation. Hippokratia. 14:28–32. 2010.PubMed/NCBI
|
|
39
|
Hirahara N, Matsubara T, Kawahara D,
Mizota Y, Ishibashi S and Tajima Y: Prognostic value of
hematological parameters in patients undergoing esophagectomy for
esophageal squamous cell carcinoma. Int J Clin Oncol. 21:909–919.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Song X, Zhu H, Pei Q, Tan F, Li C, Zhou Z,
Zhou Y, Yu N, Li Y and Pei H: Significance of inflammation-based
indices in the prognosis of patients with non-metastatic colorectal
cancer. Oncotarget. 8:45178–45189. 2017.PubMed/NCBI
|
